Navigation Links
Treatment not testicular cancer poses greatest risk to survivors' long-term health
Date:10/15/2009

than 10 per cent use their frozen samples later on.

  • Pulmonary complications can arise in men who receive the drug bleomycin before larger surgical procedures, particularly if they are aged 40 or over.

  • Radiotherapy can cause short-term nausea, vomiting and lethargy, but side-effects tend to decrease two to four weeks after therapy.

  • Cisplatin-based chemotherapy can damage the sensory nerves in 10 to 30 per cent of patients and 20 per cent of survivors complain of impaired hearing and tinnitus.

  • Most acute drug toxicity problems tend to resolve themselves, or decrease, in the first year, but long-term problems pose greater issues. Despite this, many patients are only monitored by their consultant for five to ten years, after which they may or may not be regularly seen by primary care professionals.

  • Survivors are up to 1.8 times more likely to develop a secondary cancer, particularly solid malignancies below the diaphragm. The introduction of cisplatin-based chemotherapy, and a gradual reduction in radiotherapy, does not appear to have reduced the secondary cancer risk. But it appears to reduce the risk of cancer developing in the remaining testicle.

  • Avoiding mediastinal radiotherapy has reduced the risk of chronic heart complications, but death rates are still slightly increased by infra-diaphragmatic radiotherapy. In addition, the chemotherapy drug cisplatin can cause inflammation of the endothelial cells, leading to premature thickening of the coronary arteries.

  • About 20 per cent of survivors have already suffered irreversible hypogonadism, where the testes produces little or no sex hormone, and reduced fertility before their cancer is diagnosed.

  • Removal of lymph nodes in the abdomen can lead to dry ejaculation in some patients and infra-diaphragmatic radiotherapy and chemotherapy can cause temporary reductions in fertility.

  • Surprisingly, sur
    '/>"/>

  • Contact: Annette Whibley
    wizard.media@virgin.net
    Wiley-Blackwell
    Source:Eurekalert

    Page: 1 2 3

    Related biology news :

    1. Nicotinic receptors may be important targets for treatment of multiple addictions
    2. A new radiation therapy treatment developed for head and neck cancer patients
    3. Restoring sight, advances in fertility treatments and better visibility for pilots at FIO
    4. Presence of gene mutation helps guide thyroid cancer treatment
    5. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
    6. New genetic research into nicotine addiction shows promise for personalized treatment
    7. Interleukin-8, key marker for colorectal cancer treatment
    8. New class of drug offers hope to treatment-resistant AIDS patients
    9. Paradigm shift in Alzheimerss research: new treatments
    10. New research on structure of bones raises questions for treatment of osteoporosis
    11. Major genetic breakthrough for ankylosing spondylitis brings treatment hope
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
    (Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
    (Date:12/3/2014)... GLENDALE, Ariz. , Dec. 2, 2014 ... biometric hand readers, Inception Technologies is pleased to announce ... it easier for customers to collect the workforce data ... the problems that have been left by existing readers. ... to user interface, connectivity and modern technology. Older models ...
    Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
    ... in the rugged Marquesas Islands (French Polynesia) have increased the ... research and collecting in conjunction with the Vascular Flora ... Polynesie franaise projects have yielded 62 new species of ... 360, of which 18 are newly described and illustrated in ...
    ... available in German . They live their lives upside ... position, sloths spend most of their lives hanging in trees upside ... Very slowly. But why are sloths so ,lazy,? And how has ... in the course of evolution? Zoologists of the Friedrich Schiller University ...
    ... to be genes that, when mutated, change healthy cells into ... of the University of Southern California (USC) have proven that ... paving the way to a safer and more practical approach ... cell therapy. "The reality may be more complicated than ...
    Cached Biology News:Marquesas Islands in French Polynesia yield 18 new species of rare ferns and flowering plants 2The decoding of slowness 2USC research: Cancer cells and stem cells share same origin 2
    (Date:12/22/2014)... RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a ... of autologous cell therapies, announced today the publication of ... conjunction with co-authors from Kyoto University and the University ... clinical research using dermal sheath cup (DSC) cells to ... paper entitled " Hair Follicle Dermal Stem Cells Regenerate ...
    (Date:12/22/2014)... (PRWEB) December 22, 2014 ... peer-reviewed publication of original research, reviews and editorials ... and clinical practice, today published a provocative article ... the development, progression and potential treatment of prostate ... endocrinology research and proposes the possibility that there ...
    (Date:12/19/2014)... December 19, 2014 Charm Sciences is ... for the Detection of Aflatoxin M1 in raw commingled ... independent third party validation. The peer reviewed report of ... the Institute for Agricultural and Fisheries Research (ILVO-T&V) has ... , Aflatoxin B1, the most toxic aflatoxin and a ...
    (Date:12/19/2014)... 19, 2014 Bina Technologies, Inc. (Bina, ... they have been acquired by Roche (SIX: RO, ROG; ... held company that provides a big data platform for ... data for the academic and translational research markets.  Bina ... will continue to focus on development of their innovative ...
    Breaking Biology Technology:Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
    ... - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS) today reported the ... August 31, 2008. All dollar amounts referenced,herein are in ... 2008, our cash and cash equivalents totaled $9.8 million,compared ... net loss for the third quarter of 2008 was ...
    ... 15 Quincy Bioscience (Madison, WI),announces that ... of the jellyfish protein apoaequorin, has displayed ... subjects tested. The Prevagen,Memory Study included 56 ... mg/day). The findings suggest that supplementation with,apoaequorin, ...
    ... 08/07 ... millions sales change millions sales change, ... 16 Other EU countries (2) 7.1 24 17 8.6 ... 24 1.8 5 18, SLIT ...
    Cached Biology Technology:Vasogen Announces Third Quarter 2008 Results 2Vasogen Announces Third Quarter 2008 Results 3Vasogen Announces Third Quarter 2008 Results 4Vasogen Announces Third Quarter 2008 Results 5Vasogen Announces Third Quarter 2008 Results 6Vasogen Announces Third Quarter 2008 Results 7Vasogen Announces Third Quarter 2008 Results 8Vasogen Announces Third Quarter 2008 Results 9Vasogen Announces Third Quarter 2008 Results 10Jellyfish Protein Shows Potential to Help With Memory 2Jellyfish Protein Shows Potential to Help With Memory 3Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14% 2Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14% 3
    ... Partek Genomics Solution is a comprehensive ... data visualization specifically designed to reliably ... for high-dimensional genomic studies containing thousands ... fast, memory efficient and will analyze ...
    Kit contains: Bio-Rad Amplification Reagent, 2x Amplification Diluent, Streptavidin-HRP, Blocking Reagent, and Phosphate Buffered Saline....
    These macrocarriers are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 macrocarriers....
    Intestinal Epithelium Differentiation Environment...
    Biology Products: